A
bargain priced
blended strain gummy at $0.38/g, produced in Ontario by
SPOT in the Cannabis Edibles category with 47% Lower THC* potency at
0.9mg and Nominal CBD* content at
0.1mg. Includes 49% Higher CBG* content at
3.6mg (* based on average potencies for Gummies).
Based on limited terpene and strain data, we find Gooseberry to have a
2/10 score for aid with
inflammation** including help with
infection, and overall
product score (ePS) of
4/10 when compared to products in the same category.
On-Label flavours:
berry.
Highs include: Good CBG
✦ content for category; Added THC content for category; Competitively priced. Noted observations:
No product specific written reviews available.